Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia

Molecular Psychiatry

Volumn 17, Issue 10, 2012, Pages 996-1006

  Lips, E S ^a   Cornelisse, L N ^a   Toonen, R F ^a   Min, J L ^a   Hultman, C M ^b,c   Holmans, P A ^d   O'Donovan, M C ^d   Purcell, S M ^e,f,g   Smit, A B ^a   Verhage, M ^a   Sullivan, P F ^h   Visscher, P M ⁱ   Posthuma, D ^a,j  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

GAIN; gene group analysis; genome wide association; GWAS; ISC; synapse

Indexed keywords

ARTICLE; CELL ADHESION; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE;

CALCIUM CHANNELS, L-TYPE; CASE-CONTROL STUDIES; CELL ADHESION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBMED; RISK FACTORS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 84866736529     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.117     Document Type: Article

References (35)

1. Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995; 346: 477-481.
2. Mowry BJ, Holmans PA, Pulver AE, Gejman PV, Riley B, Williams NM et al. Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry 2004; 9: 784-795.
3. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192.
4. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
5. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
6. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
7. Kim Y, Zerwas S, Trace SE, Sullivan PF. Schizophrenia genetics: where next? Schizophr Bull 2011; 37: 456-463.
8. Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008; 92: 265-272.
9. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, Sklar P et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009; 85: 13-24.
10. Jia P, Wang L, Meltzer HY, Zhao Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res 2010; 122: 38-42.
11. Ruano D, Abecasis GR, Glaser B, Lips ES, Cornelisse LN, de Jong AP et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet 2010; 86: 113-125.
12. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011; 16: 286-292.
13. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007; 23: 3251-3253.
14. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007; 81: 1278-1283.
15. Owen MJ, O'Donovan MC, Harrison PJ. Schizophrenia: a genetic disorder of the synapse? BMJ 2005; 330: 158-159.
16. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68; image 45.
17. Hayashi-Takagi A, Sawa A. Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. Brain Res Bull 2010; 83: 140-146.
18. Johnson RD, Oliver PL, Davies KE. SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim Pol 2008; 55: 619-628.
19. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854.
20. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 2006; 78: 315-333.
21. Li K, Hornshaw MP, van Minnen J, Smalla KH, Gundelfinger ED, Smit AB. Organelle proteomics of rat synaptic proteins: correlation-profiling by isotope-coded affinity tagging in conjunction with liquid chromatography-tandem mass spectrometry to reveal post-synaptic density specific proteins. J Proteome Res 2005; 4: 725-733.
22. Takamori S, Holt M, Stenius K, Lemke EA, Gronborg M, Riedel D et al. Molecular anatomy of a trafficking organelle. Cell 2006; 127: 831-846.
23. Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 2005; 18: 1368-1373.
24. Fisher RA. Statistical Methods for Research Workers. Oliver and Boyd: London, 1925.
25. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS. Truncated product method for combining P-values. Genet Epidemiol 2002; 22: 170-185.
26. Nyholt DR. A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
27. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
28. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
29. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010; 15: 1016-1022.
30. de Jong AP, Verhage M. Presynaptic signal transduction pathways that modulate synaptic transmission. Curr Opin Neurobiol 2009; 19: 245-253.
31. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-Wide Association Study Identifies Five Novel Schizophrenia Loci. Nat Genet, in press.
32. Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance MA et al. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 2010; 86: 621-625.
33. Wei Z, Wang K, Qu HQ, Zhang H, Bradfield J, Kim C et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet 2009; 5: e1000678.
34. Kitano H. Biological robustness. Nat Rev Genet 2004; 5: 826-837.
35. Stelling J, Sauer U, Szallasi Z, Doyle 3rd FJ, Doyle J. Robustness of cellular functions. Cell 2004; 118: 675-685.